Skip Navigation
Menu
ACP Journal Club |17 November 2015

After treating unprovoked PE with VKAs for 6 months, warfarin for 18 more months reduced a composite of VTE or major bleeding

Randolph J. Lipchik, MD

Article, Author, and Disclosure Information
FULL TEXT
Couturaud F, Sanchez O, Pernod G, et al; PADIS-PE Investigators. Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: the PADIS-PE randomized clinical trial. JAMA. 2015;314:31-40. 26151264

Hospitalists:

Image: rating_6.jpg

Hematol/Thrombo:

Image: rating_6.jpg

Pulmonology:

Image: rating_6.jpg

After a first pulmonary embolism (PE) treated with vitamin K antagonists (VKAs) for 6 months, what are the benefit and harms of 18 more months of warfarin treatment?
FULL TEXT
PDF
Not Available
Citations
Citation

Lipchik RJ. After treating unprovoked PE with VKAs for 6 months, warfarin for 18 more months reduced a composite of VTE or major bleeding. Ann Intern Med. 2015;163:JC6. doi: 10.7326/ACPJC-2015-163-10-006

Download citation file:

© 2018

×
Permissions

Published: Ann Intern Med. 2015;163(10):JC6.

DOI: 10.7326/ACPJC-2015-163-10-006

0 Citations

Related Articles
Update in Hematology: Evidence Published in 2014
Annals of Internal Medicine; 162 (9): W106-W110
Review: In AF or VTE, direct oral anticoagulants reduce fatal bleeding compared with vitamin K antagonists
Annals of Internal Medicine; 163 (8): JC2
Edoxaban was noninferior to warfarin for preventing recurrent venous thromboembolism, with less bleeding
Annals of Internal Medicine; 160 (2): JC4
Update in Hematology and Oncology
Annals of Internal Medicine; 152 (10): 655-662
View MoreView Less

Journal Club
Review: In AF or VTE, direct oral anticoagulants reduce fatal bleeding compared with vitamin K antagonists
Annals of Internal Medicine; 163 (8): JC2
Edoxaban was noninferior to warfarin for preventing recurrent venous thromboembolism, with less bleeding
Annals of Internal Medicine; 160 (2): JC4
In VTE, extending anticoagulation with rivaroxaban vs aspirin reduced recurrence without increasing bleeding
Annals of Internal Medicine; 166 (12): JC65
After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding
Annals of Internal Medicine; 166 (6): JC29
View MoreView Less

Related Point of Care
Acute Gastrointestinal Bleeding
Annals of Internal Medicine; 159 (3): ITC2-1
Palliative Care
Annals of Internal Medicine; 168 (5): ITC33-ITC48
Systemic Lupus Erythematosus
Annals of Internal Medicine; 159 (7): ITC4-1
Polymyalgia Rheumatica
Annals of Internal Medicine; 166 (9): ITC65-ITC80
View MoreView Less

Related Topics
Venous Thromboembolism

Venous Thromboembolism.

PubMed Articles
Letter to the Editor Regarding "Association between blood glucose and functional outcome in intracerebral hemorrhage: a systematic review and meta-analysis".
World Neurosurg 2018.
Decompressive craniotomy for malignant middle cerebral artery infarction: Optimal timing and literature review.
World Neurosurg 2018.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2018 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×